Patients with rheumatic disease who were taking hydroxychloroquine had a lower risk of COVID-19 infection than patients taking other disease-modifying anti-rheumatic drugs.
— Read on www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30227-7/fulltext